I agree that this site is using cookies. You can find further informations here.
X
Dunn, DT
77  results:
Search for persons X
?
1

Continuation of emtricitabine/lamivudine within combination..:

Stirrup, OT ; Asboe, D ; Pozniak, A...
HIV Medicine.  21 (2020)  5 - p. 309-321 , 2020
Link: https://doi.org/10.1111/..
 
?
2

HIV self‐testing intervention experiences and kit usability..:

Witzel, TC ; Bourne, A ; Burns, FM...
HIV Medicine.  21 (2019)  3 - p. 189-197 , 2019
Link: https://doi.org/10.1111/..
 
?
3

Patterns and predictors of the use of different antiretrovi..:

Easterbrook, PJ ; Phillips, AN ; Hill, T...
HIV Medicine.  9 (2008)  1 - p. 47-56 , 2008
Link: https://doi.org/10.1111/..
 
?
4

CD4 cell count and initiation of antiretroviral therapy: tr..:

Stöhr, W ; Dunn, DT ; Porter, K...
HIV Medicine.  8 (2007)  3 - p. 135-141 , 2007
Link: https://doi.org/10.1111/..
 
?
5

A prospective multicentre study of discontinuing prophylaxi..:

Green, H ; Hay, P ; Dunn, DT..
HIV Medicine.  5 (2004)  4 - p. 278-283 , 2004
Link: https://doi.org/10.1111/..
 
?
6

Effect of prenatal treatment on the risk of intracranial an..:

Gras, L ; Gilbert, RE ; Ades, AE.
International Journal of Epidemiology.  30 (2001)  6 - p. 1309-1313 , 2001
Link: https://doi.org/10.1093/..
 
?
7

Effect of prenatal treatment on mother to child transmissio..:

Gilbert, RE ; Gras, L ; Wallon, M...
International Journal of Epidemiology.  30 (2001)  6 - p. 1303-1308 , 2001
Link: https://doi.org/10.1093/..
 
?
8

Routine vaccination and vaccine‐preventable infections in c..:

Dunn, DT ; Newell, M‐L ; Peckham, CS.
Acta Paediatrica.  87 (1998)  4 - p. 458-459 , 1998
Link: https://doi.org/10.1111/..
 
?
9

Risk of human immunodeficiency virus type 1 transmission th..:

Dunn, DT ; Newell, ML ; Ades, AE.
International Journal of Gynecology & Obstetrics.  41 (1993)  1 - p. 111-111 , 1993
Link: https://doi.org/10.1016/..
 
?
10

COVAC1 phase 2a expanded safety and immunogenicity study of..:

Szubert, AJ ; Pollock, KM ; Cheeseman, HM...
https://openaccess.sgul.ac.uk/id/eprint/115173/1/COVAC1%20phase%202a%20expanded%20safety%20and%20immunogenicity%20study%20of%20a%20self-amplifying%20RNA%20vaccine%20against%20SARS-CoV-2.pdf.  , 2023
Link: https://openaccess.sgul...
 
?
11

COVAC1 phase 2a expanded safety and immunogenicity study of..:

Szubert, AJ ; Pollock, KM ; Cheeseman, HM...
EClinicalMedicine.  , 2022
Link: http://hdl.handle.net/10..
 
?
12

Safety and immunogenicity of a self-amplifying RNA vaccine ..:

Pollock, KM ; Cheeseman, HM ; Szubert, AJ...
https://discovery.ucl.ac.uk/id/eprint/10142501/1/1-s2.0-S2589537021005435-main.pdf.  , 2022
Link: https://discovery.ucl.ac..
 
?
13

Improving clinical trial interpretation with ACCEPT analyse:

Clements, M ; White, IR ; Copas, AJ...
doi:10.1056/EVIDctw2200018.  , 2022
Link: https://doi.org/10.1056/..
 
?
14

Safety and immunogenicity of a self-amplifying RNA vaccine ..:

Pollock, KM ; Cheeseman, HM ; Szubert, AJ...
https://openaccess.sgul.ac.uk/id/eprint/114347/1/1-s2.0-S2589537021005435-main.pdf.  , 2022
Link: https://openaccess.sgul...
 
?
15

Confidence limits for the averted infections ratio estimate..:

Dunn, DT ; Stirrup, OT ; Glidden, DV
https://discovery.ucl.ac.uk/id/eprint/10139282/1/Dunn_10.1515_scid-2021-0002.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
1-15